Abstract Reports indicate an increased mortality risk for solid organ transplant recipients with COVID-19 (1, 2), which may have been influenced by clinical decision making (triage) during the early phase of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic In Germany, relatively few transplant recipients were infected, and the capacity of the health care system was at no point in time overwhelmed Hereby, high capacity PCR-testing including all potential organ donors, symptomatic organ recipients or other patients, as well as a relatively high number of hospitals with intensive care units (1248) as well as transplant centers (40) with high capacities allowed a completely unimpaired organ procurement and transplantation situation throughout the first wave of the pandemic despite having SARS-CoV-2 infection rates of app 2200 per million persons at the end of May 2020 Our data lead to a different assessment of the risk associated with COVID-19 after organ transplantation
Revised Correspondence to Transplantation International: Solid Organ Transplantation is not a risk factor for COVID-19 disease outcome